Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I, Multicenter, Open-label, First-in-Human, Dose Escalation and Expansion Study of AZD9592 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumors

This is a first-in-human (FIH) Phase I, multi-center, open-label, study of AZD9592, in patients with advanced solid tumors. The study consists of several study…

Advanced Solid TumoursCarcinoma Non-small Cell LungHead and Neck Neoplasms+1 more

AstraZenecaNCT05647122